La Jolla, CA, United States of America

Helen M Ranney

This inventor holds 2 USPTO granted patents. Top assignee: Alliance Pharmaceutical Corp.. Active years: 1997-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Helen M Ranney. Retrieved from https://idiyas.com/inventor/helen-m-ranney

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 274(Granted Patents)


Company Filing History:


Years Active: 1997-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Helen M Ranney: Innovator in Pharmaceutical Solutions

Introduction

Helen M Ranney is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative solutions for the delivery of lipophilic pharmaceutical agents. With a total of 2 patents, her work has the potential to enhance the bioavailability of various medications.

Latest Patents

Helen's latest patents include groundbreaking inventions that focus on improving the delivery of lipophilic pharmaceuticals. The first patent, titled "Fluorochemical solutions for the delivery of lipophilic pharmaceutical," describes a thermodynamically stable molecular solution that enhances the bioavailability of lipophilic pharmaceutical agents. This solution comprises a liquid carrier made of one or more physiologically acceptable lipophilic fluorochemicals, along with a pharmaceutically effective amount of at least one lipophilic pharmaceutical agent. The patent also discloses methods for making and using this molecular solution.

The second patent, "Continuous fluorochemical microdispersions for the delivery of," outlines a method for preparing a pharmaceutical microdispersion that exhibits enhanced bioavailability. This method involves creating a thermodynamically stable pharmaceutical composition that incorporates at least one lipophilic pharmaceutical agent in a physiologically acceptable liquid carrier. The patent details the steps for combining this stable composition with a miscible diluent to initiate phase separation, resulting in a microdispersion of the pharmaceutical composition.

Career Highlights

Helen M Ranney is associated with Alliance Pharmaceutical Corporation, where she continues to innovate in the pharmaceutical field. Her work has garnered attention for its potential to revolutionize the way lipophilic drugs are delivered to patients.

Collaborations

Helen has collaborated with notable colleagues, including Jeffry G Weers and Luis A Dellamary, who have contributed to her research and development efforts.

Conclusion

Helen M Ranney's contributions to pharmaceutical innovations are noteworthy, particularly in the area of lipophilic drug delivery systems. Her patents reflect a commitment to enhancing the effectiveness of pharmaceutical agents, ultimately benefiting patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…